Asia Pacific Trial Sector Poised for Continued Growth

The Asia Pacific trial sector grew during the global economic downturn as sponsors sought to improve access to patients, cut costs and improve data quality according to Novotech CEO Alek Safarian.

Safarian told Outsourcing-pharma there had been a four-fold increase in trials being conducted by contract research organisations (CRO) in a number of countries in Asia Pacific, with India, Taiwan and Novotech’s base, Australia, seeing the biggest gains.

... more text ...

Notice: The copyright of this article is owned by another publisher, please visit the following website link for the full text of the article. The full access to the article is under the control of its publisher. Viewers who cannot access the article online can contact us at croasia@croasia.net for further information.

Click here to access the full article

By clicking on the above link, you will leave CROAsia.net. If you wish to return to this website, please click "Back" button or log onto CROAsia.net again.